Walmart Now Selling Biomerica’s EZ Detect™ Colorectal Screening Test
October 01, 2021 06:39 ET
|
Biomerica, Inc.
Simple 2 minute at-home test detects early warning sign of colorectal cancer IRVINE, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced...
BioNTech erweitert klinisches Onkologie-Portfolio: Erster Patient in Phase 2-Studie mit individualisierter mRNA-basierter Immuntherapie BNT122 gegen Darmkrebs behandelt
October 01, 2021 02:00 ET
|
BioNTech SE
Zweite Phase-2-Studie initiiert, die auf BioNTechs unternehmenseigener individualisierter mRNA-basierten Krebsimpfstoff-Plattform iNeST basiert Randomisierte Phase-2-Studie wird rund 200 Patienten mit...
BioNTech Expands Clinical Oncology Portfolio with First Patient Dosed in Phase 2 Trial of mRNA-based Individualized Immunotherapy BNT122 in Colorectal Cancer Patients
October 01, 2021 02:00 ET
|
BioNTech SE
Second Phase 2 trial initiated from BioNTech’s proprietary individualized mRNA-based cancer vaccine platform iNeST Randomized Phase 2 trial will enroll approximately 200 patients with high-risk...
Hundreds of Cancer Survivors and Caregivers from Across the Country to Climb for a Cure
August 17, 2021 17:44 ET
|
Fight Colorectal Cancer
Springfield, Mo., Aug. 17, 2021 (GLOBE NEWSWIRE) -- National nonprofit organization Fight Colorectal Cancer (Fight CRC) is hosting its annual hiking event on August 22, 2021, to raise awareness and...
Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology
July 06, 2021 09:00 ET
|
Auris Medical AG
Treatment of KRAS-driven colorectal cancer selected as first therapeutic indication for OligoPhore™ platformCompany to launch development program under project code AM-401 with aim of IND submission...
Alphageneron to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th, 2021
June 25, 2021 19:21 ET
|
Alphageneron Pharmaceuticals
CAMBRIDGE, Mass., June 25, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”), a privately-held clinical-stage biopharmaceutical company developing...
Provectus Biopharmaceuticals Announces Publication of In Vitro Data from Research on Oral Delivery of PV-10® at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
June 09, 2021 07:00 ET
|
Provectus Biopharmaceuticals Inc.
— PV-10 treatment induced autophagic cell death in all breast, colorectal, head and neck, and testicular cancer cell lines tested — Represents prerequisite in vitro data for clinical testing...
Advocates Mobilize To Ask President To Fund Colorectal Cancer Research
June 08, 2021 12:49 ET
|
Fight Colorectal Cancer
Springfield, Mo., June 08, 2021 (GLOBE NEWSWIRE) -- By 2030, it is estimated that colorectal cancer (CRC) will be the leading cause of cancer deaths for those ages 20-49, according to a recent JAMA...
Global Immuno-Oncology Assays Market (2021 to 2026) - Growing Significance of Companion Diagnostics Presents Opportunities
May 14, 2021 05:23 ET
|
Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Assays Market by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications...
Colorectal Cancer Treatment Market In North America Is Expected To Account For A Major Revenue Share During Forecast Period Till 2030: Acumen Research And Consulting
May 12, 2021 11:00 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, has recently published a report titled “Colorectal Cancer Treatment Market – Global Industry Analysis, Market Size,...